EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition

In this study, EGCG was added to a culture of glioma like stem cells that were enriched with glioblastoma cells and found that EGCG led to the death of the cancer cells that were treated with it and increased sensitivity to TMZ.

Recommended Posts

Notify of
Inline Feedbacks
View all comments